Page 93

Mayo_2017

639 artículo de revisión Nuevas tecnologías en el tratamiento de la diabetes - P. Apablaza et al Three Continuous Glucose Monitors: The Navigator, G4 Platinum, and Enlite. J Diabetes Sci Technol 2014; 8 (4): 699-708. 10. Bailey T, Bode B, Christiansen M, Klaff L, Alva S. The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System. Diabetes Technol Ther 2015; 17 (11): 787-94. 11. Keenan D, Mastrototaro J, Zisser H, Kooper K, Raghavendhar G, Lee S, et al. Accuracy of the Enlite 6-Day Glucose Sensor with Guardian and Veo Calibration Algorithms. Diabetes Technol Ther 2012; 14 (3): 225-31. 12. Maahs D, Calhoun P, Buckingham B, Chase H, Hramiak I, Lum J. A Randomized Trial of a Home System to Reduce Nocturnal Hypoglycemia in Type 1 Diabetes. Diabetes Care 2014; 37 (7): 1885-91. 13. Beck R, Raghinaru D, Wadwa R, Chase H, Maahs D, Buckingham B. Frequency of Morning Ketosis After Overnight Insulin Suspension Using an Automated Nocturnal Predictive Low Glucose Suspend System. Diabetes Care 2014; 37 (5): 1224-9. 14. Calhoun P, Buckingham B, Maahs D, Hramiak I, Wilson D, Aye T. Efficacy of an Overnight Predictive Low-Glucose Suspend System in Relation to Hypoglycemia Risk Factors in Youth and Adults With Type 1 Diabetes. J Diabetes Sci Technol 2016; May 20. En prensa. 15. Ang K, Tamborlane W, Weinzimer S. Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas. Expert Opin. Drug Deliv 2015; 12 (10): 1579- 82. 16. Russell S, El-Khatib F, Sinha M, Magyar K, McKeon K, Goergen L, et al. Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes. N Engl J Med 2014; 371 (4): 313-25. 17. Thabit H, Tauschmann M, Allen J, Leelarathna L, Hartnell S, Wilinska M, et al. Home Use of an Artificial Beta Cell in Type 1 Diabetes. N Engl J Med 2015; 373 (22): 2129-40. 18. Trevitt S, Simpson S, Wood A. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development? J Diabetes Sci Technol 2016; 10 (3): 714-23. 19. Grunberger G, Abelseth J, Bailey T, Bode B, Handelsman Y, Hellman R, et al. Consensus Statement by the American Association of Clinical Endocrinologists/ American College of Endocrinology Insulin Pump Management Task Force. Endocr Pract 2014; 20 (5): 463-89. 20. Peters A, Ahmann A, Battelino T, Evert A, Hirsch I, Murad M, et al. Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016 Sep. En prensa. 21. Maurizi A, Suraci C, Pitocco D, Schiaffini R, Tubili C, Morviducci L, et al. Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience. J Diabetes 2016; 8 (1): 41-4. 22. Yeh HC, Brown T, Maruthur N, Ranasinghe P, Berger Z, Suh Y. Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic Review and Meta-analysis. Ann Intern Me 2012; 157 (5): 336-47. 23. Golden S, Sapir T. Methods for Insulin Delivery and Glucose Monitoring in Diabetes: Summary of a Comparative Effectiveness Review. J Manag Care Pharm 2012; 18 (6 Suppl): S1-17. 24. Admon G, Weinstein Y, Falk B, Weintrob N, Benzaquen H, Ofan R, et al. Exercise With and Without an Insulin Pump Among Children and Adolescents With Type 1 Diabetes Mellitus. Pediatrics 2005; 116 (3): e348-55. 25. Gómez A, Gómez C, Aschner P, Veloza A, Muñoz O, Rubio C, et al. Effects of Performing Morning versus Afternoon Exercise on Glycemic Control and Hypoglycemia Frequency in Type 1 Diabetes Patients on Sensor-Augmented Insulin Pump Therapy. J Diabetes Sci Technol 2015; 9 (3): 619-24. 26. Franc S, Daoudi A, Pochat A, Petit M, Randazzo C, Petit C, et al. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Diabetes Obes Metab 2015; 17 (12): 1150-7. 27. Garg S, Brazg R, Bailey T, Buckingham B, Slover R, Klonoff D, et al. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: The In-Clinic ASPIRE Study. Diabetes Technol The 2012; 14 (3): 205- 9. 28. Bergenstal R, Klonoff D, Garg S, Bode B, Meredith M, Slover R, et al. Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia. N Engl J Med 2013; 369 (3): 224-32. 29. Ly T, Nicholas J, Retterath A, Lim E, Davis E, Jones T. Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes A Randomized Clinical Trial. JAMA 2013; 310 (12): 1240-7. 30. Choudhary P, Rickels M, Senior P, Vantyghem MC, Maffi P, Kay T, et al. Evidence-Informed Clinical Practice Recommendations for Treatment of Type 1 Diabetes Rev Med Chile 2017; 145: 630-640


Mayo_2017
To see the actual publication please follow the link above